PL1928431T3 - Kompozycja farmaceutyczna zawierająca karwedilol o kontrolowanym uwalnianiu - Google Patents

Kompozycja farmaceutyczna zawierająca karwedilol o kontrolowanym uwalnianiu

Info

Publication number
PL1928431T3
PL1928431T3 PL06779688T PL06779688T PL1928431T3 PL 1928431 T3 PL1928431 T3 PL 1928431T3 PL 06779688 T PL06779688 T PL 06779688T PL 06779688 T PL06779688 T PL 06779688T PL 1928431 T3 PL1928431 T3 PL 1928431T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
controlled release
release pharmaceutical
composition containing
containing carvedilol
Prior art date
Application number
PL06779688T
Other languages
English (en)
Inventor
Pál Fekete
Zoltán Budavari
Zsolt Zsigmond
Agnes Bozso
Huszar Magdolna Leventiszne
Zoltánné Palfi
Pálné Szentgroti
Karacs Erika Davidne
Kuncze Anikó Turoczine
Krisztina Abraham
Original Assignee
Egis Gyogyszergyar Nyilvanosan Mukoedoe Reszvenytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan Mukoedoe Reszvenytarsasag filed Critical Egis Gyogyszergyar Nyilvanosan Mukoedoe Reszvenytarsasag
Publication of PL1928431T3 publication Critical patent/PL1928431T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06779688T 2005-08-26 2006-08-23 Kompozycja farmaceutyczna zawierająca karwedilol o kontrolowanym uwalnianiu PL1928431T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0500803A HU227490B1 (en) 2005-08-26 2005-08-26 Sustained release pharmaceutical preparation containing carvedilol
PCT/HU2006/000068 WO2007023325A2 (en) 2005-08-26 2006-08-23 Controlled release pharmaceutical composition containing carvedilol
EP06779688A EP1928431B8 (en) 2005-08-26 2006-08-23 Controlled release pharmaceutical composition containing carvedilol

Publications (1)

Publication Number Publication Date
PL1928431T3 true PL1928431T3 (pl) 2009-07-31

Family

ID=89986232

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06779688T PL1928431T3 (pl) 2005-08-26 2006-08-23 Kompozycja farmaceutyczna zawierająca karwedilol o kontrolowanym uwalnianiu

Country Status (11)

Country Link
EP (1) EP1928431B8 (pl)
AT (1) ATE418969T1 (pl)
DE (1) DE602006004610D1 (pl)
DK (1) DK1928431T3 (pl)
EA (1) EA013058B1 (pl)
ES (1) ES2321980T3 (pl)
HU (1) HU227490B1 (pl)
NO (1) NO20081481L (pl)
PL (1) PL1928431T3 (pl)
PT (1) PT1928431E (pl)
WO (1) WO2007023325A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
ES2646326T3 (es) 2005-08-03 2017-12-13 Sprout Pharmaceuticals, Inc. Uso de flibanserina en el tratamiento de la obesidad
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
RU2428176C2 (ru) * 2006-01-27 2011-09-10 Юранд, Инк. Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
EP2054041A2 (en) 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulations of flibanserin and method for manufacturing the same
IL197129A (en) 2006-08-25 2014-08-31 Boehringer Ingelheim Int Controlled release system and method for production
HU227881B1 (en) * 2007-02-23 2012-05-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Sustained release pharmaceutical preparation containing carvedilol
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
CN101801357B (zh) 2007-09-21 2013-08-07 赢创罗姆有限公司 耐受乙醇的影响的pH依赖性受控释放的药物组合物
WO2009047800A2 (en) * 2007-10-09 2009-04-16 Lupin Limited Oral controlled release composition of carvedilol
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN103099793B (zh) * 2013-02-06 2015-07-15 中国人民解放军第二军医大学 片剂及其制备方法
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426811A1 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems

Also Published As

Publication number Publication date
HU0500803D0 (en) 2005-11-28
ES2321980T3 (es) 2009-06-15
EA013058B1 (ru) 2010-02-26
DE602006004610D1 (de) 2009-02-12
PT1928431E (pt) 2009-03-25
EA200800666A1 (ru) 2008-06-30
EP1928431B8 (en) 2009-04-08
NO20081481L (no) 2008-05-19
EP1928431A2 (en) 2008-06-11
EP1928431B1 (en) 2008-12-31
HU227490B1 (en) 2011-07-28
WO2007023325A3 (en) 2007-06-28
DK1928431T3 (da) 2009-04-20
HUP0500803A2 (en) 2007-05-29
HUP0500803A3 (en) 2008-03-28
WO2007023325A2 (en) 2007-03-01
ATE418969T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
NO20081481L (no) Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning
WO2009113703A3 (en) Orally-disintegrating solid preparation
MX2010003304A (es) Suplemento alimenticio granular.
PL2150575T3 (pl) Kompozycja powłoki antyadhezyjnej i sposób jej wytwarzania
WO2007149801A3 (en) Enteric coated particles containing an active ingredient
WO2010053306A3 (ko) 메칠페니데이트의 방출 제어용 약제학적 조성물
LT1840145T (lt) Acetileno karbamido dariniai - polikarbamido polimerai ir mikrokapsulės ir kompozicijos jų kontroliuojamam atpalaidavimui
MX2010001500A (es) Dioxido de titanio fotoactivo en materiales de revestimiento.
WO2008073942A3 (en) Pharmaceutical compositions and their methods of use
WO2011060256A3 (en) Bilayer tablet formulations
EP2049331A4 (en) MULTILAYER FILM COMPOSITIONS, PACKAGED PRODUCTS AND METHOD OF USE THEREOF
WO2006099514A3 (en) Drug delivery compositions and related methods
WO2009106831A3 (en) Pharmaceutical composition comprising naltrexone
WO2011007285A3 (en) Multiple component materials having a color-changing composition
MX2012008908A (es) Pelicula que se puede rotular con laser resistente al calor.
WO2012091408A3 (en) Matrix type antimicrobial vehicle and manufacturing method thereof
WO2009152167A3 (en) Delivery of therapeutics
WO2009149058A8 (en) Modified release niacin formulations
WO2007113207A3 (en) Coated formulations
WO2006029772A3 (de) Thixotrope beschichtungsmassen
WO2010079052A3 (en) Nanoparticle compositions
WO2005099372A3 (en) Release agent-free, multiple-use, polymer-based composite materials employed for concrete pouring forms and methods of making and using the same
WO2010004299A3 (en) Pharmaceutical compositions of somatotrophic hormones
WO2008102192A3 (en) Controlled release pharmaceutical compositions
WO2008021756A3 (en) Support matrix for use in fuel cell and method of forming the same